1. Home
  2. GRPN vs CGEM Comparison

GRPN vs CGEM Comparison

Compare GRPN & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRPN
  • CGEM
  • Stock Information
  • Founded
  • GRPN 2008
  • CGEM 2016
  • Country
  • GRPN United States
  • CGEM United States
  • Employees
  • GRPN N/A
  • CGEM N/A
  • Industry
  • GRPN Advertising
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRPN Consumer Discretionary
  • CGEM Health Care
  • Exchange
  • GRPN Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • GRPN 534.1M
  • CGEM 506.1M
  • IPO Year
  • GRPN 2011
  • CGEM 2021
  • Fundamental
  • Price
  • GRPN $18.78
  • CGEM $8.46
  • Analyst Decision
  • GRPN Buy
  • CGEM Strong Buy
  • Analyst Count
  • GRPN 4
  • CGEM 7
  • Target Price
  • GRPN $17.75
  • CGEM $32.86
  • AVG Volume (30 Days)
  • GRPN 1.5M
  • CGEM 533.0K
  • Earning Date
  • GRPN 05-08-2025
  • CGEM 05-14-2025
  • Dividend Yield
  • GRPN N/A
  • CGEM N/A
  • EPS Growth
  • GRPN N/A
  • CGEM N/A
  • EPS
  • GRPN N/A
  • CGEM N/A
  • Revenue
  • GRPN $492,557,000.00
  • CGEM N/A
  • Revenue This Year
  • GRPN $2.91
  • CGEM N/A
  • Revenue Next Year
  • GRPN $6.73
  • CGEM N/A
  • P/E Ratio
  • GRPN N/A
  • CGEM N/A
  • Revenue Growth
  • GRPN N/A
  • CGEM N/A
  • 52 Week Low
  • GRPN $7.75
  • CGEM $6.85
  • 52 Week High
  • GRPN $19.85
  • CGEM $30.19
  • Technical
  • Relative Strength Index (RSI)
  • GRPN 68.13
  • CGEM 58.75
  • Support Level
  • GRPN $18.36
  • CGEM $7.38
  • Resistance Level
  • GRPN $19.60
  • CGEM $8.10
  • Average True Range (ATR)
  • GRPN 1.26
  • CGEM 0.51
  • MACD
  • GRPN -0.12
  • CGEM 0.15
  • Stochastic Oscillator
  • GRPN 88.03
  • CGEM 89.58

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering a variety of products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: